As we discussed in our last conference call, Arrowhead has reached a point where our business requires a greater degree of focus. We are in the process of building out our expertise within the cardiometabolic space and focusing more of our spend in that area.

May 9, 2024 / CEO / receipt, needs a key / Dr. Chris Anzalone, CEO | earnings call 2024-05-09 | transcript a8bb166d-30de-4644-b254-597ab0b3d85d | chars 2163-2422 | segment 2